Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Génome Québec catalyzes excellence in genomics by funding over $1 billion in projects since its founding. It provides advanced genomic technologies to researchers across health care, environment, agrifood and forestry sectors. Its investments have enabled major advances in personalized medicine—including cell/gene therapy development—and large-scale population biobanking.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Génome Québec.